Clinical Trial Update: SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating the safety of combining trabectedin with irinotecan in Ewing sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• Camptosar (irinotecan)
• Yondelis (trabectedin)

Snippet

Sponsor: Sarcoma Alliance for Research through Collaboration | Conditions: Ewing Sarcoma | Phase 1, Phase 2 | Status: COMPLETED